Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial (Q30318384)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2017

Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2017

7

0 references

Sebastian Nuding

1

0 references

5

0 references

Ursula Müller-Werdan

6

object named as

Ursula Müller-Werdan

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2017

author name string

Henning Ebelt

2

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2017

Robert S Hoke

3

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2017

Annette Krummenerl

4

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2017

publication date

3 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2017

Clinical Research in Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2017

100

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2017

915-923

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2017

Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Ivabradine for the treatment of stable angina pectoris in octogenarians

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Efficacy and safety of recombinant human activated protein C for severe sepsis

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Early goal-directed therapy in the treatment of severe sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Beta-adrenergic receptor-dependent and -independent stimulation of adenylate cyclase is impaired during severe sepsis in humans

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Metabolism modulators in sepsis: propranolol

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Effect of propranolol administration on hemodynamic and metabolic responses of burned pediatric patients

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Reversal of catabolism by beta-blockade after severe burns

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Beta-blockade during sepsis: inspired or insane?

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Vascular pathophysiology in response to increased heart rate

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Heart rate reduction--a mechanism of benefit?

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Electrophysiological effects of S 16257, a novel sino-atrial node modulator, on rabbit and guinea-pig cardiac preparations: comparison with UL-FS 49

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Drug insight: If inhibitors as specific heart-rate-reducing agents

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

A single intravenous dose of ivabradine, a novel I(f) inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Autonomic dysfunction in the ICU patient

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Impaired regulation of cardiac function in sepsis, SIRS, and MODS.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Cardiovascular parameters and scoring systems in the evaluation of response to therapy in sepsis and septic shock.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-011-0323-2

21 January 2018

Association of tachycardia with morbidity and mortality: pathophysiological considerations

1 reference

https://pubmed.ncbi.nlm.nih.gov/21638157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Septic cardiomyopathy - A not yet discovered cardiomyopathy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21638157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of a thyroid hormone infusion on vasopressor support in critically ill children with cessation of neurologic function.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21638157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of early IgM-enriched immunoglobulin vs polyvalent IgG administration in score-identified postcardiac surgical patients at high risk for sepsis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21638157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endotoxin impairs the human pacemaker current If.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21638157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of definitions and parameters for sepsis assessment in patients after cardiac surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/21638157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21638157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Autonomic dysfunction and beta-adrenergic blockers in multiple organ dysfunction syndrome]

1 reference

https://pubmed.ncbi.nlm.nih.gov/21638157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21638157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The multifactor primary prevention trial in Göteborg, Sweden

1 reference

https://pubmed.ncbi.nlm.nih.gov/21638157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21638157

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00392-011-0323-2

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30318384&oldid=2194741163"